Julien Planchon-Masliah
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 160 publications
Corrigendum to "Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis" The Lancet Regional Health - Europe, Volume 60, January 2026, 101524.
Journal: The Lancet regional health. Europe
Published: July 30, 2026
Prognostic factors in adult patients with medulloblastoma.
Journal: Neuro-oncology practice
Published: March 09, 2026
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.
Journal: The Journal of clinical investigation
Published: February 12, 2026
New Observations on a Low-Grade Diffusely Infiltrative Tumour, SMARCB1 Mutant, Arguing for a New Tumour Type.
Journal: Neuropathology and applied neurobiology
Published: January 29, 2026
Primary Cutaneous SWI/SNF-Deficient Carcinomas: Morphologic, Immunohistochemical, and Molecular Analysis of Seven Cases.
Journal: The American journal of surgical pathology
Published: January 20, 2026
Genomic characterization of aggressiveness in pituitary neuroendocrine tumors.
Journal: Neuro-oncology
Published: January 15, 2026
Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort study.
Journal: EClinicalMedicine
Published: December 22, 2025
BARD1 and breast cancer genetic predisposition: case-control study and HRD signature analysis.
Journal: Breast cancer (Tokyo, Japan)
Published: December 05, 2025
Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort study.
Journal: The Lancet. Child & adolescent health
Published: October 31, 2025
DNMT3B plays antagonistic roles with SMARCB1 and is a targetable vulnerability in rhabdoid tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 15, 2025
Atypical Neuroblastoma With Absent Urinary Catecholamine Excretion and 123ImIBG Avidity Are of Favorable Outcome: A Retrospective French Single-Center Study.
Journal: Pediatric blood & cancer
Published: September 04, 2025
Author Correction: A founder BRCA1 exonic duplication involving breakpoint in T2T reference genome-specific region results in constitutional fusion transcript.
Journal: NPJ genomic medicine
Published: September 02, 2025
Last Updated: 09/26/2026